{
    "nctId": "NCT05005650",
    "briefTitle": "Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy",
    "officialTitle": "Survival Impact of Internal Mammary or Supraclavicular Lymphadenectomy on Stage IVB Ovarian Cancer With Supradiaphragmatic Lymph Node Metastasis",
    "overallStatus": "COMPLETED",
    "conditions": "Ovarian Cancer Stage IV, Lymph Node Metastases",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 121,
    "primaryOutcomeMeasure": "Progression-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically diagnosed ovarian, fallopian tubal, primary peritoneal cancer\n* Patients suspected of metastatic lymph nodes in the cardiophrenic, internal mammary, and/or supraclavicular lymph node by CT (size larger than 5mm)\n* Patients clinically diagnosed FIGO stage IVB ovarian, fallopian tubal, primary peritoneal cancer\n* Patients underwent debulking surgery (primary debulking surgery or interval debulking surgery) at Seoul National University Hospital from January 2010 to January 2020\n* Patients age 18-90\n\nExclusion Criteria:\n\n* Borderline or benign ovarian disease\n* Patient didn't undergo debulking surgery\n* Non-epithelial ovarian cancer",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}